His lab will focus on advancing immuno‑oncology and microbiome innovation and research on understanding and interrupting tumor–immune interactionsContinue reading
Author Archive: AZBio
Internationally recognized oncology drug development leader and melanoma expert joins HonorHealth Research Institute
Dr. Nageatte Ibrahim helped guide the clinical development of Keytruda, one of the most consequential immuno-oncology therapiesContinue reading
Celebrating the Life and Impact of Dick Mallery
Dick Mallery was more that a business attorney. Passionate about the city he called home, a patron of the arts, and a champion for health innovation, Dick Mallery lived a life that crafted a lasting legacy.
New TGen Clinical Test for Multiple Myeloma Consolidates Multiple Analyses and Provides Detailed Information in 3 Days
JAYseq, a powerful new whole genome sequencing assay delivers a comprehensive, 72 hour molecular profile to help oncologists personalize care for patients across the myeloma disease spectrum
HonorHealth Research Institute explores a new way to treat type 2 diabetes without drugs
Restore-1 clinical trial uses steam to refresh part of the small intestine in an effort to restore natural blood-sugar controlContinue reading
ASU Health’s alliance with HonorHealth to benefit researchers, students — and Arizona residents who never step foot in a classroom
As primary clinical affiliate for the John Shufeldt School of Medicine and Medical Engineering, HonorHealth opens up opportunities for improving care for the stateContinue reading
TGen, City of Hope study surveys dysfunctional gene splicing in metastatic kidney disease
Aberrant splicing helps predict therapeutic responses in patients with metastatic renal cell
J. Craig Venter, genomics pioneer, dies at 79
La Jolla, California—April 29, 2026—The J. Craig Venter Institute (JCVI) announced that J. Craig Venter, Ph.D., the Institute’s founder, board chair, and chief executive officer, died today in San Diego following a brief hospitalization for unexpected side effects that arose from treatment of recently diagnosed cancer.
Dr. Venter was a visionary scientific leader whose work helped define modern genomics and launch the field of synthetic biology. He drove scientific and technological change by building interdisciplinary teams, pushing for bold ideas and faster methods, and insisting that discovery should translate into real-world impact. He was also a fierce advocate for robust federal science funding and for partnerships that accelerate progress across government, academia, and industry.Continue reading